368 related articles for article (PubMed ID: 17661814)
41. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
[TBL] [Abstract][Full Text] [Related]
42. An autopsy case of G
Uchino A; Nagai M; Kanazawa N; Ichinoe M; Yanagisawa N; Adachi K; Nanba E; Ishiura H; Mitsui J; Tsuji S; Suzuki K; Murayama S; Nishiyama K
Neuropathology; 2020 Aug; 40(4):379-388. PubMed ID: 32219895
[TBL] [Abstract][Full Text] [Related]
43. Beta-galactosidase deficiencies and novel GLB1 mutations in three Chinese patients with Morquio B disease or GM1 gangliosidosis.
Lei HL; Ye J; Qiu WJ; Zhang HW; Han LS; Wang Y; Gu XF
World J Pediatr; 2012 Nov; 8(4):359-62. PubMed ID: 23151865
[TBL] [Abstract][Full Text] [Related]
44. Mutation analysis of GM1 gangliosidosis in a Siamese cat from Japan in the 1960s.
Uddin MM; Tanimoto T; Yabuki A; Kotani T; Kuwamura M; Chang HS; Yamato O
J Feline Med Surg; 2012 Dec; 14(12):900-2. PubMed ID: 22772479
[TBL] [Abstract][Full Text] [Related]
45. Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis.
Allende ML; Lee YT; Byrnes C; Li C; Tuymetova G; Bakir JY; Nicoli ER; James VK; Brodbelt JS; Tifft CJ; Proia RL
J Lipid Res; 2023 Dec; 64(12):100463. PubMed ID: 37871851
[TBL] [Abstract][Full Text] [Related]
46. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.
Weismann CM; Ferreira J; Keeler AM; Su Q; Qui L; Shaffer SA; Xu Z; Gao G; Sena-Esteves M
Hum Mol Genet; 2015 Aug; 24(15):4353-64. PubMed ID: 25964428
[TBL] [Abstract][Full Text] [Related]
47. Identification of Bangladeshi domestic cats with GM1 gangliosidosis caused by the c.1448G>C mutation of the feline GLB1 gene: case study.
Uddin MM; Hossain MA; Rahman MM; Chowdhury MA; Tanimoto T; Yabuki A; Mizukami K; Chang HS; Yamato O
J Vet Med Sci; 2013; 75(3):395-7. PubMed ID: 23123943
[TBL] [Abstract][Full Text] [Related]
48. [Identification and pathogenicity prediction of a novel GLB1 variant c.101T>C (p.Ile34Thr) in an infant with GM1 gangliosidosis].
Lan XR; Qiu JW; Li H; Cai XR; Song YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jan; 21(1):71-76. PubMed ID: 30675867
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B.
Przybilla MJ; Ou L; Tăbăran AF; Jiang X; Sidhu R; Kell PJ; Ory DS; O'Sullivan MG; Whitley CB
Mol Genet Metab; 2019 Feb; 126(2):139-150. PubMed ID: 30528226
[TBL] [Abstract][Full Text] [Related]
50. A computational approach to analyse the amino acid variants of GLB1 protein causing GM1 Gangliosidosis.
Priyanka K; Madhana Priya N; Magesh R
Metab Brain Dis; 2021 Mar; 36(3):499-508. PubMed ID: 33394287
[TBL] [Abstract][Full Text] [Related]
51. Gene Editing Corrects
Leclerc D; Goujon L; Jaillard S; Nouyou B; Cluzeau L; Damaj L; Dubourg C; Etcheverry A; Levade T; Froissart R; Dréano S; Guillory X; Eriksson LA; Launay E; Mouriaux F; Belaud-Rotureau MA; Odent S; Gilot D
CRISPR J; 2023 Feb; 6(1):17-31. PubMed ID: 36629845
[TBL] [Abstract][Full Text] [Related]
52. Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.
Chen JC; Luu AR; Wise N; Angelis R; Agrawal V; Mangini L; Vincelette J; Handyside B; Sterling H; Lo MJ; Wong H; Galicia N; Pacheco G; Van Vleet J; Giaramita A; Fong S; Roy SM; Hague C; Lawrence R; Bullens S; Christianson TM; d'Azzo A; Crawford BE; Bunting S; LeBowitz JH; Yogalingam G
J Biol Chem; 2020 Sep; 295(39):13532-13555. PubMed ID: 31481471
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis of feline GM1 gangliosidosis by enzyme assay of cultured conjunctival cells.
Nowakowski RW; Thompson JN; Baker HJ
Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):487-90. PubMed ID: 3125124
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of distribution of mouse beta-galactosidase in the adult GM1-gangliosidosis brain.
Broekman ML; Tierney LA; Benn C; Chawla P; Cha JH; Sena-Esteves M
Gene Ther; 2009 Feb; 16(2):303-8. PubMed ID: 18818671
[TBL] [Abstract][Full Text] [Related]
55. Transient high-level expression of beta-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA.
Balestrin RC; Baldo G; Vieira MB; Sano R; Coelho JC; Giugliani R; Matte U
Braz J Med Biol Res; 2008 Apr; 41(4):283-8. PubMed ID: 18392450
[TBL] [Abstract][Full Text] [Related]
56. Normal serum beta-galactosidase in juvenile GM1 gangliosidosis.
Ishii N; Oshima A; Sakuraba H; Fukuyama Y; Suzuki Y
Pediatr Neurol; 1994 Jun; 10(4):317-9. PubMed ID: 8068159
[TBL] [Abstract][Full Text] [Related]
57. beta-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement.
Morrone A; Bardelli T; Donati MA; Giorgi M; Di Rocco M; Gatti R; Parini R; Ricci R; Taddeucci G; D'Azzo A; Zammarchi E
Hum Mutat; 2000; 15(4):354-66. PubMed ID: 10737981
[TBL] [Abstract][Full Text] [Related]
58. Gene symbol: GLB1. Disease: GM1 gangliosidosis infantile.
Drousiotou A; Georgiou T; Drousiotou A; Campos Y; Caciotti A; Sztriha L; Gururaj A; Ozand P; Zammarchi E; Morrone A; d Azzo A
Hum Genet; 2005 May; 116(6):542. PubMed ID: 15991327
[No Abstract] [Full Text] [Related]
59. Primary and secondary elastin-binding protein defect leads to impaired elastogenesis in fibroblasts from GM1-gangliosidosis patients.
Caciotti A; Donati MA; Bardelli T; d'Azzo A; Massai G; Luciani L; Zammarchi E; Morrone A
Am J Pathol; 2005 Dec; 167(6):1689-98. PubMed ID: 16314480
[TBL] [Abstract][Full Text] [Related]
60. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
Suzuki Y
Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
